Lung Cancer: Harnessing Advances In Immunotherapy and Radiation
Presented by Aaron Lisberg, MD and Percy Lee, MD
About the Lecture
Doctors Aaron Lisberg, MD, UCLA Clinical Instructor of Medicine and Percy Lee, MD, Associate Professor and Vice Chair of Education of Radiation Oncology will discuss recent advances in the treatment of lung cancer in the fields of immunotherapy and radiation therapy, respectively. An emphasis will be placed on how both immunotherapy and radiation therapy can be tailored to best serve each individual patient. Recent advances in immunotherapy have provided great benefits for patients with lung cancer. Similarly, recent advances in image-guided precision-oriented radiotherapy have led to better tumor eradication and reduced side effects. There is also data suggesting that the combination of radiotherapy and immunotherapy is synergistic in improving patient outcome in lung cancer. Finally, the multidisciplinary nature of lung cancer care and the clinical trials program at UCLA will be discussed.
About the Speakers
Dr. Percy Lee is an Associate Professor and Vice Chair of Education for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center. He serves as the Residency Training Program Director. Dr. Lee attended the Johns Hopkins University and graduated with the highest honors majoring in Biomedical Engineering with a concentration in Chemical Engineering. He attended Harvard Medical School and the Harvard-MIT Health Science and Technology program (HST) where he received his M.D. and graduated Magna cum laude. At Harvard, he was also a Howard Hughes Medical Institute fellow. He interned at the Massachusetts General Hospital and received specialty training in Radiation Oncology from Stanford University School of Medicine. Dr. Lee is the Clinical Director of the Stereotactic Body Radiation Therapy (SBRT) program and the Chief of Service for the Thoracic Radiation Oncology programs in the department.
Dr. Aaron Lisberg is a Clinical Instructor of Medicine at UCLA in the Division of Hematology/Oncology and the co-author of multiple peer-reviewed publications. His primary research interests include immunotherapy, lung cancer, and head and neck cancer. Dr. Lisberg completed medical school at the University of Minnesota, internal medicine residency at the University of Washington, and hematology/oncology fellowship at UCLA.